In vivo and in vitro production options for fungal secondary metabolites

Molecular Pharmaceutics

Volumn 5, Issue 2, 2008, Pages 234-242

  Schneider, Patrick ^a   Misiek, Mathias ^a   Hoffmeister, Dirk ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Biotransformation; Fungi; Genomics; Heterologous expression; Natural products; Pharmaceutical biotechnology; Secondary metabolism

Indexed keywords

NATURAL PRODUCT;

ANTIMICROBIAL ACTIVITY; CHEMICAL STRUCTURE; DRUG CYTOTOXICITY; DRUG TRANSFORMATION; FUNGAL METABOLISM; FUNGUS CULTURE; GENE CLUSTER; GENETIC CORRELATION; GENOME ANALYSIS; HETEROLOGOUS EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; INSECTICIDAL ACTIVITY; MICROARRAY ANALYSIS; PEPTIDE SYNTHESIS; PHARMACOPHORE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW;

ANTI-BACTERIAL AGENTS; BIOLOGICAL PRODUCTS; BIOTRANSFORMATION; FUNGI; GENOMICS;

EID: 42549126178     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp7001544     Document Type: Review

References (63)

1. Keller, N. P.; Turner, G.; Bennett, J. W. Fungal secondary metabolism - from biochemistry to genomics. Nat. Rev. Microbiol. 2005, 3, 937-947.
2. Koehn, F. E.; Carter, G. T. The evolving role of natural products in drug discovery. Nat. Rev. Drug Discovery 2005, 4, 206-220.
3. Gullo, V. P.; McAlpine, J.; Lam, K. S.; Baker, D.; Petersen, F. Drug discovery from natural products. J. Ind. Microbiol. Biotechnol. 2006, 33, 523-531.
4. Lam, K. S. New aspects of natural products in drug discovery. Trends Microbiol. 2007, 15, 279-289.
5. Misiek, M.; Hoffmeister, D. Fungal genetics, genomics, and secondary metabolites in pharmaceutical sciences. Planta Med. 2007, 73, 103-115.
6. Wilkinson, B.; Micklefield, J. Mining and engineering natural-product biosynthetic Pathways. Nat. Chem. Biol. 2007, 3, 379-386.
7. Hoffmeister, D.; Keller, N. P. Natural products of filamentous fungi: enzymes, genes, and their regulation. Nat. Prod. Rep. 2007, 24, 393-416.
8. Newman, D. L.; Cragg, G. M.; Snader, K. M. Natural Products as Sources of New Drugs over the Period 1981-2002. J. Nat. Prod. 2003, 66, 1022-1037.
9. Newman, D. L.; Cragg, G. M. Natural Products as Sources of New Drugs over the Last 25 Years. J. Nat. Prod. 2007, 70, 461-477.
10. Galagan, J. E.; Calvo, S. E.; Cuomo, C.; Ma, L. J.; Wortman, J. R.; Batzoglou, S.; Lee, S. I.; Basturkmen, M.; Spevak, C. C.; Clutterbuck, J. Sequencing of Aspergillus nidulans and comparative analysis with A. fumigatus and A. oryzae. Nature 2005, 438, 1105-1115.
11. Payne, G. A.; Nierman, W. C.; Wortman, J. R.; Pritchard, B. L.; Brown, D.; Dean, R. A.; Bhatnagar, D.; Cleveland, T. E.; Machida, M.; Yu, J. Whole genome comparison of Aspergillus flavus and A. oryzae. Med. Mycol. 2006, 44, S9-S11.
12. Masurekar, P. S. Strain improvement for the production of fungal secondary metabolites. In Handbook of Industrial Mycology; An, Z., Ed., Marcel Dekker: New York, 2005; pp 539561.
13. Elander, R. P. Industrial production of beta-lactam antibiotics. Appl. Microbiol. Biotechnol. 2003, 61, 385-392.
14. 0 production by fermentation of the fungus Glarea lozoyensis: physiological and engineering factors affecting titer and structural analogues formation. In Handbook of Industrial Mycology; An, Z., Ed.; Marcel Dekker: New York, 2005; pp 515-538..
15. Bode, H. B.; Bethe, B.; Hofs, R.; Zeeck, A. Big effects from small changes: possible ways to explore nature's chemical diversity. ChemBioChem 2002, 3, 619-627.
16. Wilkinson, R. A.; Strobel, G.; Stierle, A. Sphaeric acid, a new succinic acid derivative from a Sphaeropsis sp. J. Nat. Prod. 1999, 62, 358-360.
17. Paranagama, P. A.; Wijeratne, E. M.; Gunatilaka, A. A. Uncovering Biosynthetic Potential of Plant-Associated Fungi: Effect of Culture Conditions on Metabolite Production by Paraphaeosphaeria quadriseptata and Chaetomium chiversii. J. Nat. Prod. 2007, 70, 1939-1945.
18. Hawksworth, D. L. The magnitude of fungal diversity: the 1.5 million species estimate revisited. Mycol. Res. 2001, 105, 1422-1432.
19. Müller-Kuhrt, L. Putting nature back into drug discovery. Nat. Biotechnol. 2003, 21, 602.
20. Koch, M. A.; Schuffenhauer, A.; Scheck, M.; Wetzel, S.; Casaulta, M.; Odermatt, A.; Ertl, P.; Waldmann, H. Charting biologically relevant chemical space: A structural classification of natural products (SCONP). Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 17272-17277.
21. Chartrain, M.; Sturr, M. Fungal bioconversions: applications to the manufacture of pharmaceuticals In Handbook of Industrial Mycology; An, Z., Ed.; Marcel Dekker: New York, 2005; pp 563-595.
22. Kennedy, J. Mutasynthesis, chemobiosynthesis, and back to semi-synthesis: combining synthetic chemistry and biosynthetic engineering for diversifying natural products. Nat. Prod. Rep. 2008, 25, 25-34.
23. Demain, A. L.; Elander, E. P. The beta-lactam antibiotics: past, present, and future. Antonie van Leeuwenhoek 1999, 75, 5-19.
24. Xu, Y.; Zhan, J.; Kithsiri, E. M.; Burns, A. M.; Gunatilaka, A. A. L.; Molnár, I. Cytotoxic and Antihaptotactic Beauvericin Analogues from Precursor-Directed Biosynthesis with the Insect Pathogen Beauveria bassiana ATCC 7159. J. Nat. Prod. 2007, 70, 1467-1471.
25. Zhan, J.; Gunatilaka, A. A. L. Microbial Transformation of Amino-and Hydroxyanthraquinones by Beauveria bassiana ATCC 7159. J. Nat. Prod. 2006, 69, 1525-1527.
26. Wigley, L. J.; Mantle, P. G.; Perry, D. A. Natural and directed biosynthesis of communesin alkaloids. Phytochemistry 2006, 67, 561-569.
27. Cannell, R. J.; Dawson, M. J.; Hale, R. S.; Hall, R. M.; Noble, D.; Lynn, S.; Taylor, N. L. The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. IV. Preparation of fluorinated squalestatins by directed biosynthesis. J. Antibiot. 1993, 46, 1381-1389.
28. Nevalainen, K. M.; Te'o, V. S.; Bergquist, P. L. Heterologous protein expression in filamentous fungi. Trends Biotechnol. 2005, 23, 468-474.
29. Xie, X.; Watanabe, K.; Wojcicki, W. A.; Wang, C. C.; Tang, Y. Biosynthesis of Lovastatin Analogs with a Broadly Specific Acyltransferase. Chem. Biol. 2006, 13, 1161-1169.
30. Skatrud, P. L. Genetic engineering of beta-lactam antibiotic biosynthetic pathways in filamentous fungi. Trends Biotechnol. 1992, 10, 324-329.
31. Kennedy, J.; Turner, G. δ-(L-α-aminoadipyl)-L-cysteinyl-D- valine synthethase is a rate limiting enzyme for penicillin production in Aspergillus nidulans. Mol. Gen. Genet. 1996, 253, 189-197.
32. Ullán, R. V.; Campoy, S.; Casqueiro, J.; Fernandez, F. J.; Martín, J. F. Deacetylcephalosporin C production in Penicillium chrysogenum by expression of the isopenicillin N epimerization, ring expansion, and acetylation genes. Chem. Biol. 2007, 14, 329-339.
33. Kennedy, J.; Auclair, K.; Kendrew, S. G.; Park, C.; Vederas, J. C.; Hutchinson, C. R. Modulation of polyketide synthase activity by accessory proteins during lovastatin biosynthesis. Science 1999, 284, 1368-1372.
34. Sorensen, J. L.; Vederas, J. C. Monacolin N, a compound resulting from derailment of type I iterative polyketide synthase function en route to lovastatin. Chem. Commun. 2003, 1492-1493.
35. Ma, S. M.; Zhan, J.; Watanabe, K.; Xie, X.; Zhang, W.; Wang, C. C.; Tang, Y. Enzymatic synthesis of aromatic polyketides using PKS4 from Gibberella fujikuroi. J. Am. Chem. Soc. 2007, 129, 10642-10643.
36. Ma, S. M.; Zhan, J.; Xie, X.; Watanabe, K.; Tang, Y.; Zhang, W. Redirecting the Cyclization Steps of Fungal Polyketide Synthase. J. Am. Chem. Soc. 2008, 130, 38-39.
37. Feifel, S. C.; Schmiederer, T.; Hornbogen, T.; Berg, H.; Süssmuth, R. D.; Zocher, R. In vitro synthesis of new enniatins: probing the alpha-D-hydroxy carboxylic acid binding pocket of the multienzyme enniatin synthetase. ChemBioChem 2007, 8, 1767-1770.
38. Schneider, P.; Weber, M.; Rosenberger, K.; Hoffmeister, D. A one-pot chemoenzymatic synthesis for the universal precursor of antidiabetes and antiviral bis-indolylquinones. Chem. Biol. 2007, 14, 635-644.
39. Balibar, C. J.; Howard-Jones, A. R.; Walsh, C. T. Terrequinone A biosynthesis through L-tryptophan oxidation, dimerization and bisprenylation. Nat. Chem. Biol. 2007, 3, 584-592.
40. Machida, M.; Asai, K.; Sano, M.; Tanaka, T.; Kumagai, T.; Terai, G.; et al. Genome sequencing and analysis of Aspergillus oryzae. Nature 2005, 438, 1157-1161.
41. Pel, H. P.; de Winde, J. H.; Archer, D. B.; Dyer, P. S.; Hofmann, G.; Schaap, P. J.; et al. Genome sequencing and analysis of the versatile cell factory Aspergillus niger CBS 513.88. Nat. Biotechnol. 2007, 25, 221-231.
42. Askenazi, M.; Driggers, E. M.; Holtzman, D. A.; Norman, T. C.; Iverson, S.; Zimmer, D. P.; et al. Integrating transcriptional and metabolite profiles to direct the engineering of lovastatin-producing fungal strains. Nat. Biotechnol. 2003, 21, 150-156.
43. Bok, J. W.; Hoffmeister, D.; Maggio-Hall, L.; Murillo, R.; Glasner, J.; Keller, N. P. Genomic Mining for Aspergillus Natural Products. Chem. Biol. 2006, 13, 31-37.
44. Bouhired, S.; Weber, M.; Kempf-Sontag, A.; Keller, N. P.; Hoffmeister, D. Accurate prediction of the Aspergillus nidulans terrequinone gene cluster boundaries using the transcriptional regulator LaeA. Fungal Genet. Biol. 2007, 44, 1134-1145.
45. Perrin, R. M.; Fedorova, N. D.; Bok, J. W.; Cramer, R. A.; Wortman, J. R.; Kim, H. S.; Nierman, W. C.; Keller, N. P. Transcriptional regulation of chemical diversity in Aspergillus fumigatus by LaeA. PLoS Pathog. 2007, 3, e50.
46. Bergmann, S.; Schümann, J.; Scherlach, K.; Lange, C.; Brakhage, A. A.; Hertweck, C. Genomics-driven discovery of PKS-NRPS hybrid metabolites from Aspergillus nidulans. Nat. Chem. Biol. 2007, 3, 213-217.
47. Scherlach, K.; Hertweck, C. Discovery of aspoquinolones A-D, prenylated quinoline-2-one alkaloids from Aspergillus nidulans, motivated by genome mining. Org. Biomol. Chem. 2006, 4, 3517-3520.
48. Jacobs, M. R. Retapamulin: a semisynthetic pleuromutilin compound for topical treatment of skin infections in adults and children. Future Microbiol. 2007, 2, 591-600.
49. Yeo, W.; Boyer, M.; Chung, H. C.; Ong, S. Y.; Lim, R.; Zee, B.; et al. Irofulven as first line therapy in recurrent or metastatic gastric cancer: a phase II multicenter study by the Cancer Therapeutics Research Group (CTRG). Cancer Chemother. Pharmacol. 2007, 59, 295-300.
50. McMorris, T. C.; Chimmani, R.; Gurram, M.; Staake, M. D.; Keiner, M. J. Synthesis and antitumor activity of amine analogs of irofulven. Bioorg. Med. Chem. Lett. 2007, 17, 6770-6772.
51. Saleem, M.; Ali, M. S.; Hussain, S.; Jabbar, A.; Ashraf, M.; Lee, Y. S. Marine natural products of fungal origin. Nat. Prod. Rep. 2007, 24, 1142-1152.
52. Nicholson, B.; Lloyd, G. K.; Miller, B. R.; Palladino, M. A.; Kiso, Y.; Hayashi, Y.; Neuteboom, S. T. NPI-2358 is a tubulin-depolymerizing agent: in-vitro evidence for activity as a tumor vascular-disrupting agent. Anticancer Drugs 2006, 17, 25-31.
53. Paranagama, P. A.; Wijeratne, E. M.; Burns, A. M.; Marron, M. T.; Gunatilaka, M. K.; Arnold, A. E.; Gunatilaka, A. A. Heptaketides from Corynespora sp. Inhabiting the Cavern Beard Lichen Usnea cavernosa: First Report of Metabolites of an Endolichenic Fungus. J. Nat. Prod. 2007, 70, 1700-1705.
54. Kemami Wangun, H. V.; Dahse, H.-M.; Hertweck, C. Epicoccarines A, B and epipyridone: tetramic acids and pyridone alkaloids from an Epicoccum sp. associated with the tree fungus Pholiota squarrosa. Org. Biomol. Chem. 2007, 5, 1702-1705.
55. Lee, T.; Yun, S. H.; Hodge, K. T.; Humber, R. A.; Krasnoff, S. B.; Turgeon, G. B.; Yoder, O. C.; Gibson, D. M. Polyketide synthase genes in insect- and nematode-associated fungi. Appl. Microbiol. Biotechnol. 2001, 56, 181-187.
56. Krasnoff, S. B.; Sommers, C. H.; Moon, Y. S.; Donzelli, B. G.; Vandenberg, J. D.; Churchill, A. C.; Gibson, D. M. Production of mutagenic metabolites by Metarhizium anisopliae. J. Agric. Food. Chem. 2006, 54, 7083-7088.
57. Strobel, G.; Daisy, B.; Castillo, U.; Harper, J. Natural products from endophytic microorganisms. J. Nat. Prod. 2004, 67, 257-268.
58. Gunatilaka, A. A. Natural products from plant-associated microorganisms: distribution, structural diversity, bioactivity, and implications of their occurrence. J. Nat. Prod. 2006, 69, 509-526.
59. Schardl, C. L.; Grossmann, R. B.; Nagabhyru, P.; Faulkner, J. R.; Mallik, U. P. Loline alkaloids: Currencies of mutualism. Phytochemistry 2007, 68, 980-996.
60. Blankenship, J. D.; Spiering, M. J.; Wilkinson, H. H.; Fannin, F. F.; Bush, L. P.; Schardl, C. L. Production of loline alkaloids by the grass endophyte Neotyphodium uncinatum, in defined media. Phytochemistry 2001, 58, 395-401.
61. Ahimsa-Müller, M. A.; Markert, A.; Hellwig, S.; Knoop, V.; Steiner, U.; Drewke, C.; Leistner, E. Clavicipitaceous Fungi Associated with Ergoline Alkaloid-Containing Convolvulaceae. J. Nat. Prod. 2007, 70, 1955-1960.
62. Strobel, G. A. Harnessing endophytes for industrial microbiology. Curr. Opin. Microbiol. 2006, 9, 240-244.
63. Partida-Martinez, L. P.; Hertweck, C. Pathogenic fungus harbours endosymbiotic bacteria for toxin production. Nature 2005, 437, 884-888.